Literature DB >> 3082699

Association between NIDDM, RH blood group, and haptoglobin phenotype. Results from the San Antonio Heart Study.

M P Stern, R E Ferrell, M Rosenthal, S M Haffner, H P Hazuda.   

Abstract

We examined seven red cell antigen and 10 polymorphic protein phenotypes in 1237 Mexican Americans randomly selected from three San Antonio neighborhoods. Statistically significant associations were found between non-insulin-dependent diabetes mellitus (NIDDM) and RH blood type (X2 = 32.87, df = 10, P = 0.0003) and haptoglobin phenotype (X2 = 9.15, df = 2, P = 0.010). The haptoglobin association showed a dose effect with a single dose of the haptoglobin-1 allele associated with an approximately 50% increase and a double dose of the haptoglobin-1 allele associated with an approximately 100% increase in NIDDM prevalence. Multivariate analysis indicated statistically significant associations between NIDDM and age, sex, adiposity, and neighborhood of residence. However, even after taking these potential confounding variables into account, there was still a significant, independent association between NIDDM and haptoglobin phenotype. The results suggest that the haptoglobin gene may be in linkage disequilibrium with a major susceptibility gene for NIDDM.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3082699     DOI: 10.2337/diab.35.4.387

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  12 in total

1.  Haptoglobin 2-2 genotype is associated with increased risk of type 2 diabetes mellitus in northern Chinese.

Authors:  Xiaohong Shi; Liang Sun; Li Wang; Feng Jin; Junfeng Sun; Xiaoquan Zhu; Lei Tang; Yanchun Qu; Ze Yang
Journal:  Genet Test Mol Biomarkers       Date:  2012-02-02

2.  Haptoglobin polymorphism and association with complications in ghanaian type 2 diabetic patients.

Authors:  Michael B Adinortey; Ben A Gyan; Jonathan P Adjimani; Philomena E Nyarko; Charity Sarpong; Francis Y Tsikata; Alexander K Nyarko
Journal:  Indian J Clin Biochem       Date:  2011-05-13

Review 3.  Type 2 (non-insulin-dependent) diabetes mellitus. New genetics for old nightmares.

Authors:  S O'Rahilly; J S Wainscoat; R C Turner
Journal:  Diabetologia       Date:  1988-07       Impact factor: 10.122

Review 4.  Relationships of ABO and Rhesus blood groups with type 2 diabetes mellitus: a systematic review and meta-analysis.

Authors:  Solomon Getawa; Biruk Bayleyegn; Melak Aynalem; Yilkal Belete Worku; Tiruneh Adane
Journal:  J Int Med Res       Date:  2022-10       Impact factor: 1.573

5.  Type 2 diabetes mellitus and ABO/Rh blood groups.

Authors:  Forouzan Moinzadeh; Gholamreza Mahdieh Najafabady; Ali Toghiani
Journal:  J Res Med Sci       Date:  2014-04       Impact factor: 1.852

6.  HLA-associated susceptibility to type 2 (non-insulin-dependent) diabetes mellitus: the Wadena City Health Study.

Authors:  S S Rich; L R French; J M Sprafka; J P Clements; F C Goetz
Journal:  Diabetologia       Date:  1993-03       Impact factor: 10.122

7.  Gm3;5,13,14 and type 2 diabetes mellitus: an association in American Indians with genetic admixture.

Authors:  W C Knowler; R C Williams; D J Pettitt; A G Steinberg
Journal:  Am J Hum Genet       Date:  1988-10       Impact factor: 11.025

8.  Shared genetic susceptibility of type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetes mellitus: contributions of HLA and haptoglobin.

Authors:  S S Rich; S S Panter; F C Goetz; B Hedlund; J Barbosa
Journal:  Diabetologia       Date:  1991-05       Impact factor: 10.122

9.  Genetic studies of type 2 (non-insulin-dependent) diabetes mellitus: lack of association with seven genetic markers.

Authors:  S Iyengar; R F Hamman; J A Marshall; J Baxter; P P Majumder; R E Ferrell
Journal:  Diabetologia       Date:  1989-09       Impact factor: 10.122

10.  Genetic analysis of haptoglobin polymorphisms with cardiovascular disease and type 2 diabetes in the Diabetes Heart Study.

Authors:  Jeremy N Adams; Amanda J Cox; Barry I Freedman; Carl D Langefeld; J Jeffrey Carr; Donald W Bowden
Journal:  Cardiovasc Diabetol       Date:  2013-02-11       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.